Theo Verrips

Papers

Total Citations

H-Index

About

Theo Verrips is a pioneering structural biologist and immunologist whose work has fundamentally advanced the field of single-domain antibody engineering. His research centers on the unique properties of heavy chain-only antibodies (HCAbs) derived from camelids, particularly llamas, and their transformative potential in therapeutic applications. Verrips’ most impactful contribution lies in demonstrating that llamas can produce broadly neutralizing antibodies against HIV-1, a feat that had eluded conventional immunization approaches. His landmark 2014 study, which has garnered 46 citations, revealed the molecular evolution of llama antibodies targeting the conserved CD4-binding site of HIV-1, providing a critical blueprint for vaccine design. This work showcased the remarkable ability of these small, stable nanobodies to access epitopes inaccessible to conventional antibodies, opening new avenues for HIV prevention and treatment. Beyond HIV, Verrips has been instrumental in establishing nanobody platforms for diagnostics and therapeutics, with his research consistently highlighting the versatility of these molecules. His pioneering efforts have not only reshaped our understanding of antibody evolution but have also laid the groundwork for next-generation biologics, cementing his legacy as a visionary in molecular immunology.